Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Patterson, a dental products distributor, agrees to $4.1B sale to healthcare investor
Medtech Dive
Thu, 12/12/24 - 11:38 am
Patterson Companies
dental
M&A
Medtech
Tenpoint, Visus merge in effort to push presbyopia-correcting eye drop over FDA finish line
Fierce Biotech
Thu, 12/12/24 - 11:38 am
Tenpoint Therapeutics
Visus Therapeutics
presbyopia
M&A
Reverse, reverse: Liver disease biotech Hepion and Pharma Two B call off merger
Fierce Biotech
Wed, 12/11/24 - 10:49 pm
M&A
Hepion Pharmaceuticals
Pharma Two B
liver disease
How the Omnicom-IPG merger could reshape pharma marketing
Medical Marketing and Media
Wed, 12/11/24 - 11:29 am
pharma marketing
Omnicom
IPG
M&A
How Trump’s second term will affect the medtech industry
Medtech Dive
Wed, 12/11/24 - 11:28 am
Medtech
Donald Trump
tarriffs
M&A
CDRH
LDTs
Roche said it didn’t want to buy Poseida last year: A look at how the $1.5B buyout came to be
Fierce Biotech
Tue, 12/10/24 - 10:00 pm
Roche
Poseida Therapeutics
M&A
cell therapy
With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close
Fierce Pharma
Sun, 12/8/24 - 09:37 pm
Novo Holdings
Catalent
Europe
M&A
CDMOs
Pharma hopes Trump will bring change to the FTC. They may be disappointed.
BioPharma Dive
Mon, 12/2/24 - 07:39 pm
pharma industry
FTC
Donald Trump
M&A
Top 8 Trends That Helped Define the Medical Device Industry in 2024
Medical Devices and Diagnostics Industry
Mon, 12/2/24 - 11:04 am
Medtech
digital health
CGMs
LDTs
sustainability
pulsed field ablation
artificial intelligence
M&A
robotic surgery
Roche to buy cell therapy developer Poseida for $1B
BioPharma Dive
Tue, 11/26/24 - 11:24 am
Roche
Poseida Therapeutics
M&A
cell therapy
cancer
Halozyme abandons its €2bn pursuit of Evotec
Pharmaphorum
Mon, 11/25/24 - 09:29 am
Halozyme Therapeutics
Evotec
M&A
Medtronic Acquires Fortimedix Surgical
Medical Devices and Diagnostics Industry
Thu, 11/21/24 - 10:46 pm
Medtech
Medtronic
Fortimedix
M&A
Novartis buys Kate Therapeutics, eyeing $55B CGT market opportunity by 2030
BioSpace
Thu, 11/21/24 - 11:54 am
Novartis
Kate Therapeutics
M&A
gene therapy
Henry Schein to acquire medical supplier Acentus
Medtech Dive
Thu, 11/21/24 - 11:44 am
Henry Schein
Acentus
M&A
Medtech
CGMs
Incyte sinks on setback for drugs acquired in $750M buyout
BioPharma Dive
Tue, 11/19/24 - 07:10 pm
Incyte
Escient Pharma
M&A
Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug
Pharma Voice
Mon, 11/18/24 - 11:12 am
Merck
Modifi Biosciences
M&A
glioblastoma
brain cancer
Boston Sci Closes Acquisition of Medtronic’s Neuromodulation Foe
Medical Devices and Diagnostics Industry
Fri, 11/15/24 - 11:10 am
Boston Scientific
Medtech
Axonics
neuromodulation
M&A
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink
Fierce Pharma
Wed, 11/13/24 - 09:49 pm
M&A
Bristol Myers Squibb
Amgen
patent cliffs
BioNTech to buy Biotheus, gaining control of cancer bispecific
BioPharma Dive
Wed, 11/13/24 - 11:30 am
BioNTech
M&A
Biotheus
Summit Therapeutics
cancer bispecifics
Pfizer explores sale of hospital drugs unit
CNBC/Reuters
Tue, 11/12/24 - 11:19 am
Pfizer
M&A
hospital drugs
Starboard Value
Pfizer Hospital
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »